Advanced
search

Search results

1 – 9 of 9
View access options
Expert briefing
Publication date: 13 February 2024
Expert Briefings Powered by Oxford Analytica

The NDP has long pushed for a national pharmacare programme, and a lack of action would provide an excuse for Singh to end the 2022 pact with the Liberals that has helped keep the…

Details

DOI: 10.1108/OXAN-DB285185

ISSN: 2633-304X

Keywords

Geographic
Canada
NA
Topical
politics
social
election
government
health
legislation
party
pharmaceutical
policy
population
private sector
reform
economy
fiscal
View access options
Executive summary
Publication date: 7 March 2017
Expert Briefings Powered by Oxford Analytica

UNITED STATES: Obamacare set for protracted battle

Details

DOI: 10.1108/OXAN-ES218456

ISSN: 2633-304X

Keywords

Geographic
United States
NA
Topical
economy
industry
politics
social
fiscal
government
health
insurance
legislation
party
pharmaceutical
View access options
Executive summary
Publication date: 3 March 2017
Expert Briefings Powered by Oxford Analytica

UNITED STATES: Republicans will fracture on Obamacare

Details

DOI: 10.1108/OXAN-ES218391

ISSN: 2633-304X

Keywords

Geographic
United States
NA
Topical
economy
industry
politics
social
fiscal
government
health
insurance
legislation
party
pharmaceutical
View access options
Expert briefing
Publication date: 5 February 2020
Expert Briefings Powered by Oxford Analytica

For Trump, yesterday’s address was part constitutional duty and part election speech. The speech was also given one day before the Republican-led Senate is expected to acquit…

View access options
Expert briefing
Publication date: 17 August 2016
Expert Briefings Powered by Oxford Analytica

Post-default politics in Puerto Rico.
View access options
Expert briefing
Publication date: 12 July 2019
Expert Briefings Powered by Oxford Analytica

Trudeau will spend the summer campaigning for re-election, defending his administration’s record while underscoring unfinished business for a second term.
View access options
Expert briefing
Publication date: 2 June 2021
Expert Briefings Powered by Oxford Analytica

Some of Canada’s largest provincial governments have seen their approval ratings fall in the wake of the third wave, although there has been little impact on the Liberal…

Details

DOI: 10.1108/OXAN-DB261841

ISSN: 2633-304X

Keywords

Geographic
Canada
NA
Topical
politics
social
biotechnology
government
health
party
pharmaceutical
View access options
Executive summary
Publication date: 11 March 2019
Expert Briefings Powered by Oxford Analytica

UNITED STATES: 2020 budget fight is imminent
View access options
Expert briefing
Publication date: 8 April 2020
Expert Briefings Powered by Oxford Analytica

Congress has passed three COVID-19 relief packages, which include payroll support for shuttered businesses to retain employees. Congress now eyes a fourth package to expand…

Access

Year

Content type

Refine By Country
{"C":[{"count":"3","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22+AND+keyword-country%3A%22Canada%22"},{"count":"2","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22+AND+keyword-country%3A%22China%22"}],"M":[{"count":"2","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22+AND+keyword-country%3A%22Mexico%22"}],"P":[{"count":"1","title":"Puerto Rico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22+AND+keyword-country%3A%22Puerto+Rico%22"}],"U":[{"count":"7","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22social%22+AND+keyword-geographic%3A%22NA%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 9 of 9
Manage cookies

We’re listening — tell us what you think

Join us on our journey